Retinal Physician

JAN-FEB 2017

Issue link:

Contents of this Issue


Page 30 of 71

R E T I N A L P H Y S I C I A N | J A N U A R Y / F E B R U A R Y 2 0 1 7 29 components. 23 Immunohistochemistry can identify antiretinal antibodies, most common of which are antirecoverin and anti- alpha-enolase antibodies. 20 Myotonic Dystrophy e classic ocular finding in myotonic dystrophy is the "Christmas tree cataract," a posterior subcapsular, red and green, iridescent opacification of the lens. Patients can pres- ent with other ophthalmic findings including ocular hypotony and pigmentary retinopathy (Figure 7) that can be confused for AMD. 24,25 e pathognomonic systemic feature is muscle weakness and myotonia of the distal legs, hands, neck and face. 26 Fundus examination can reveal butterfly-shaped macu- lar pigmentary changes, peripheral reticular pigmentation and peripheral polygonal-shaped atrophy. 27 FAF of the macular pigmentary changes demonstrates a branching linear pattern of mixed hyper- and hypoautofluorescence. 28 Macular OCT of these changes identifies patches of inderdigitation zone hyper- reflectivity and ellipsoid zone hyporeflectivity. 28 CONCLUSION Despite the prevalence of dry AMD, it is important for ophthalmologists to consider less common diseases and multi-modal imaging to arrive at the correct diagnosis. As demonstrated in this series, numerous pathologies have over- lapping features with dry AMD, including pattern dystrophies, cone-rod dystrophies, medication toxicities, and systemic disor- ders associated with maculopathies. Other common disorders with overlapping features of dry AMD include inactive central serous retinopathy and other "pachychoroid"-related maculop- athies, particularly in older patients, as these entities can cause macular pigmentary changes. Historical and exam features that raise suspicion of "Dry AMD-masquerade syndromes" include younger age, suspect medications and systemic disorders, family history, highly symmetric macular pathology and lack of typi- cal drusen. Cuticular drusen and flecks, as demonstrated above, as well as dominant drusen (Malattia Leventinese), and even crystalline retinopathies such as tamoxifen maculopathy, could mimic drusen. Ancillary testing with red-free photography, FA, FAF, macular OCT and ERG can be helpful in further charac- terizing the retinal pathology. Newer techniques such as OCT with enhanced depth imaging can be used to demonstrate thickened choroid, which is characteristic of central serous reti- nopathy and other "pachychoroid"-related maculopathies. In the future, genetic testing will become commonplace, and will further delineate many of these maculopathies. RP REFERENCES 1. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta- analysis. The Lancet Global health. 2014;2(2):e106-116. 2. Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina (Philadelphia, Pa). 2010;30(9):1441-1454. 3. Boon CJ, van de Ven JP, Hoyng CB, den Hollander AI, Klevering BJ. Cuticular drusen: stars in the sky. Progress in retinal and eye research. 2013;37:90-113. 4. Boon CJ, Klevering BJ, Hoyng CB, et al. Basal laminar drusen caused by compound heterozygous variants in the CFH gene. American journal of human genetics. 2008;82(2):516-523. 5. Cohen SY, Meunier I, Soubrane G, Glacet-Bernard A, Coscas GJ. Visual function and course of basal laminar drusen combined with vitelliform macular detachment. The British journal of ophthalmology. 1994;78(6):437-440. 6. Khan KN, Mahroo OA, Khan RS, et al. Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes. Progress in retinal and eye research. 2016;53:70-106. 7. Leys A, Vanrenterghem Y, Van Damme B, Snyers B, Pirson Y, Leys M. Fundus chang- es in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 1991;229(5):406-410. 8. van de Ven JP, Boon CJ, Fauser S, et al. Clinical evaluation of 3 families with basal laminar drusen caused by novel mutations in the complement factor H gene. Archives of ophthalmology (Chicago, Ill : 1960). 2012;130(8):1038-1047. 9. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Mosby; 1997. 10. Boon CJ, van Schooneveld MJ, den Hollander AI, et al. Mutations in the peripherin/ RDS gene are an important cause of multifocal pattern dystrophy simulating STGD1/ fundus flavimaculatus. The British journal of ophthalmology. 2007;91(11):1504- 1511. 11. Roy R, Kumar S, Chandrasekharan DP, Ghose A, Sharma P. Multimodal imaging in multifocal pattern dystrophy simulating fundus flavimaculatus. Indian journal of ophthalmology. 2016;64(5):395-396. 12. Rocha Bastos R, Ferreira CS, Brandao E, Falcao-Reis F, Carneiro AM. Multimodal Image Analysis in Acquired Vitelliform Lesions and Adult-Onset Foveomacular Vitel- liform Dystrophy. Journal of ophthalmology. 2016;2016:6037537. 13. Chowers I, Tiosano L, Audo I, Grunin M, Boon CJ. Adult-onset foveomacular vitelliform dystrophy: A fresh perspective. Progress in retinal and eye research. 2015;47:64-85. 14. Grob S, Yonekawa Y, Eliott D. Multimodal imaging of adult-onset foveomacular vitelliform dystrophy. Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. 2014;28(2):104-110. 15. Querques G, Forte R, Querques L, Massamba N, Souied EH. Natural course of adult-onset foveomacular vitelliform dystrophy: a spectral-domain optical coherence tomography analysis. American journal of ophthalmology. 2011;152(2):304-313. 16. Thiadens AA, Phan TM, Zekveld-Vroon RC, et al. Clinical course, genetic etiology, and visual outcome in cone and cone-rod dystrophy. Ophthalmology. 2012;119(4):819-826. 17. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA ophthalmology. 2014;132(12):1453-1460. 18. Chen E, Brown DM, Benz MS, et al. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign). Clinical ophthalmology (Auckland, NZ). 2010;4:1151-1158. 19. Kellner U, Renner AB, Tillack H. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine. Investigative ophthalmology & visual science. 2006;47(8):3531-3538. 20. Khan N, Huang JJ, Foster CS. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome. Seminars in ophthalmology. 2006;21(3):135-141. 21. Grange L, Dalal M, Nussenblatt RB, Sen HN. Autoimmune retinopathy. American journal of ophthalmology. 2014;157(2):266-272.e261. 22. Rahimy E, Sarraf D. Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Survey of ophthalmology. 2013;58(5):430-458. 23. Pepple KL, Cusick M, Jaffe GJ, Mruthyunjaya P. SD-OCT and autofluorescence characteristics of autoimmune retinopathy. The British journal of ophthalmology. 2013;97(2):139-144. 24. Ikeda KS, Iwabe-Marchese C, Franca MC, Jr., Nucci A, Carvalho KM. Myotonic dys- trophy type 1: frequency of ophthalmologic findings. Arquivos de neuro-psiquiatria. 2016;74(3):183-188. 25. Rosa N, Lanza M, Borrelli M, et al. Low intraocular pressure resulting from ciliary body detachment in patients with myotonic dystrophy. Ophthalmology. 2011;118(2):260-264. 26. TD. B. Myotonic Dystrophy Type 1. In: Pagon RA, Adam MP, Ardinger HH, et al, edi- tors GeneReviews® [Internet]. 1999 Sep 17 [Updated 2015 Oct 22].(Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: https://www.ncbi. 27. Kimizuka Y, Kiyosawa M, Tamai M, Takase S. Retinal changes in myotonic dystrophy. Clinical and follow-up evaluation. Retina (Philadelphia, Pa). 1993;13(2):129-135. 28. Esteves F, Dolz-Marco R, Hernandez-Martinez P, Diaz-Llopis M, Gallego-Pinazo R. Pattern dystrophy of the macula in a case of steinert disease. Case reports in ophthalmology. 2013;4(3):129-133. 29 R E T I N A L P H Y S I C I A N . C O M | J A N U A R Y / F E B R U A R Y 2 0 1 7

Articles in this issue

Links on this page

Archives of this issue

view archives of Retinal Physician - JAN-FEB 2017